Efficacy and safety of escherichia coli-derived recombinant human bone morphogenetic protein-2 in additional posterolateral lumbar fusion: Minimum 1 year follow-up

• Sang Hoon Park,
• Hee-Jung Son,
• Sung Hoon Choi,
• Haewon Jeong,
• Chang-Nam Kang

Affiliations

Sang Hoon Park

Department of Orthopedic Surgery, Hanyang University College of Medicine, Seoul, Republic of Korea

Hee-Jung Son

Department of Orthopedic Surgery, Hanyang University College of Medicine, Seoul, Republic of Korea

Sung Hoon Choi

Department of Orthopedic Surgery, Hanyang University College of Medicine, Seoul, Republic of Korea

Haewon Jeong

Department of Orthopedic Surgery, Hanyang University College of Medicine, Seoul, Republic of Korea

Chang-Nam Kang

Department of Orthopedic Surgery, Hanyang University College of Medicine, Seoul, Republic of Korea